Chemotherapy drugs Flashcards

1
Q

Alkylating drugs (including platinum)

A

Cyclophosphamide, Ifosfamide, cisplatin, carboplatin, oxaliplatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Mechanism of alkylating drug class

A

Cell cycle NON specific. Causes cross linking of base pairs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Toxicities from typical alkylating agents?

A
  1. Myelosuppression
  2. Nausea/vomitting
  3. Secondary malignancies
  4. Infertility/impaired fertility
  5. Hemorrhagic cystis
    - Ifosfamide produces more acrolein than cyclophosphamide. So need to give Mesna to prevent renal issues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Toxicities from atypical alkylating agents (platinum compounds)

A
  1. Peripheral neuropathies
    - Oxaliplatin: cold sensitivity
  2. Nephrotoxic (cisplatin)
    - Prevention with forced diuresis, mannitol.
    - Increased creatinine 3-6 days after administartion
    - Magnesium wasting
  3. Nausea/vomiting (cisplatin)
  4. Thrombocytopenia (carboplatin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Roles of methotrexate? Toxicities?

A

Works as a folate antagonist inhibiting DHFR. Toxicity: Mucositis, myelosuppression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Role of 5-fluorouracil? Toxicities?

A

Works as a pyrimidine analogue by inhibiting thymidylate synthase. Toxicities: Continuous infusion leads to GI symptoms (mucositis, diarrhea). Bolus dose leads to myelosuppression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Role of Capecitbatine? Toxicities?

A

Works as a pyrimidine analogue. Toxicities: Hand-foot syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Role of cytarabine (Ara-C)? Toxicities?

A

Works as a pyrimidine antagonist. Continuous infusion and high dose. Toxicities with high dose: Cerebellar toxicity (increased incidence with renal dysfunction, cr>2), conjunctivities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Role of 6-mercaptopurine? Toxicities?

A

Works as a purine antagonist. Toxicities: Not mentioned??

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Types of microtubule targeting agents?

A
  1. Vincas
  2. Taxanes
  3. Topoisomerase I inhibs
  4. Topoisomerase II inhibts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Mechanism of vincas? Examples? Toxicities?

A

Mechanism: M-phase Microtubular destruction
Examples: Vincristine, vinblastine
Toxicities: Cumulative neurotoxicities, variable myelsuppresion (vinblastine>vincristine), FATAL IF GIVEN INTRATHECALLY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Mechanism of Taxanes? Examples? Toxicities?

A

Mechanism: M-phase Microtubular stabilization
Examples: Abraxane (paclitaxel protein-bound particles) paclitaxel, docetaxel
Toxicities: Myelosuppresion, peripheral neuropathies, hypersensitivity. Cremaphor diluent in paclitaxel>Tween80 in docetaxel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Mechanism of Topoisomere I inhibitors? Examples? Toxicities?

A

Mechanism: Inhibits enzyme responsible for relaxing supercoiled DNA, preventing transcription
Examples: Topetecan, irinotecan
Toxicities: Myelosuppresion, Diarrhea (early onset is self-limiting-give atropine, late onset is life threatening-give as much loperamide as you need)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mechanism of Topoisomere II inhibitors? Examples? Toxicities?

A

Mechanism: Inhibits enzyme responsible for recoiling DNA after transcription
Examples: Etoposide
Toxicities: Myelosuppresion, secondary malignancies (AML11q23), dose dependent mucositis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mechanism of Anthracyclines? Examples? Toxicities?

A

Mechanism: Intercalates DNA and inhibits topoisomerase. Secondary mechiansm includes free radical damage and perhaps some alkylation
Examples: Doxorubicin (most solid tumors), daunorubicin (acute leukemias), idarubicin, epirubicin (breast cancer)
Toxicities: All cause cumulative, dose-dependent biventricular heart failure. Extravasation. Myelosuppresion, mucositis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are 2 Differentiating agents? Toxicities?

A
  1. All trans retinoic acid
  2. Arsenic trioxicde
    Toxicities: Cardiotoxicity with electrolyte abnormalities (Arsenic) Differentiation syndrome
17
Q

Examples of antitumor antibiotics? Toxicities?

A

Examples: Bleomycin and Proteasome inhibitor (Bortezomib)
Toxicities: Pulmonary toxicity (Bleomycin); Proteasome inhibitor: Fatigue, weakness, malaise, neuropathy, thrombocytopenia

18
Q

Mechanism of immunomodulating agents (atypical therapeutics) (Imids)? Examples? Toxicities?

A

Mechanism: Antiangiogenesis through inhibition of VEGF
Example: Thalidomide and lenalidomide
Toxicities: Neuropathy, thromboembolism

19
Q

Mechanism of biologic response modifiers? Examples? Toxicities?

A

Mechanism: Modulation of host immune system to enchance recognition and antineoplastic effects
Examples: Interferon and IL-2
Toxicities: Flu-like symptoms, depression/psychiatric symptoms

20
Q

Example of hormonal therapy anti-estrogens (2)

A

Tamoxifen and fulvestrant (used for Breast cancer)

21
Q

Example of hormonal therapy aromatase inhibitors (3)

A

Anastrozole, letrozole, and Exemestane (irreversible) (used for Breast cancer)

22
Q

Example of hormonal therapy for antiandrogens (3)

A

Flutamide, Bicalutamide, Nilutamide (used for prostate cancer)

23
Q

Example of hormonal thearpy LHRH agonists (2)

A

Leuprolide, Goserelin (Used for tumor “flare and prostate cancer)

24
Q

Example of hormonal thearpy GnRH anatognists (1)

A

Degarelix (Used for prostate cancer)

25
Example of hormonal therapy CYP17 inhibitors (1)
Abiraterone (androgen biosynthesis inhibitor) (Used for prostate cancer)
26
Order of monoclonal antibodies from murine to human
Murine (100%): Muromonab Chimeric (33%): Cetuximab, rituximab Humanized (10%): Bevacizumab, trastuzumab Human (0%): Panitumumab
27
Mechanism of bevacizumab and associated toxicities
Mechanism: Monoclonal antibody directed against VEGF-R Toxicties: Proteinuria, GI perforation
28
Mechanism of Cetuximab and associated toxicities
Mechanism: Monoclonal antibody directed against EGFR Toxicities: Severe hypersensitivity reactions, acneiform rash (correlates with survival)
29
Mechanism of Imatinib and toxicities
Mechanism: Protein tyrosine kinase inhibitor that inhibits the Bcr-Abl tyrosine kinase gene. This inhibits proliferation and induces apoptosis in Bcr-Abl positive cell lines Toxicties: Acneiform rash (more associated with EGFR directed therapies)
30
Mechanism of ipilimumab and toxicities
Mechaniasm: Monoclonal antibody that blocks CTLA-4. CTLA-4 typically tones down the immune system. So this drug therefore helps T-cells remain active. Toxicities: Rash, diarrhea, liver toxicity, hypophysitis